Pro Brain

Pro Brain, licence 80062994: inactive licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

Natural health product licensed in Canada

Other names: Memory Supremacy
Licence holder: Naka Herbs & Vitamins Ltd.
NPN or DIN-HM: 80062994
Status: Inactive licence
Licence date: 27 July 2015
Revision date: 6 January 2016
Form: Capsule, dur
Route of administration: Orale
Application type: Non traditionnelle

If this product were sold in France

Dose déclarée au-delà d'une limite
Vitamine B6: up to 50 mg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 2 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
À vérifier
Vitamine B6: up to 50 mg a day according to the dosing instructions published by Health Canada, above the limite de sécurité from EFSA for adults (12 mg a day). Le repère de l'EFSA porte sur l'apport total d'une journée, alimentation et compléments.
limite supérieure de sécurité (UL). EFSA, Overview on Tolerable Upper Intake Levels (version 11, August 2025), retrieved 21 October 2026.
Conditions légales
Ginkgo biloba L.: L'étiquetage des compléments alimentaires qui contiennent la feuille de la plante Ginkgo biloba L. doit comporter un avertissement avec la teneur suivante: "Consultez votre médecin en cas de prise simultanée d'anticoagulants."
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and source	Per dosage unit, according to the source	Maximum per day, adult
Withania somnifera Source : Racine Extraction ratio : 8:1 Dry plant equivalent : 1000 milligramme	125.0 milligramme	Not calculated
L-théanine Source : L-Théanine	50.0 milligramme	Not calculated
Bacopa monnieri Source : Plante entière Potency : 45.0 % Bacosides	150.0 milligramme	Not calculated
L-alpha-Glycérophosphorylcholine Source : Alfoscérate de choline	25.0 milligramme	Not calculated
Rosmarinus officinalis Source : Feuille Extraction ratio : 13:1 Dry plant equivalent : 650 milligramme	50.0 milligramme	Not calculated
Curcuma longa Source : Rhizome Extraction ratio : 25:1 Dry plant equivalent : 1250 milligramme	50.0 milligramme	Not calculated
Ginkgo biloba Source : Feuille Extraction ratio : 50:1 Dry plant equivalent : 2750 milligramme Potency : 24.0 % Flavonoid glycosides	55.0 milligramme	Not calculated
Ginkgo biloba Source : Feuille Potency : 6.0 % Terpene lactones	Not specified	Not calculated
Niacine Source : Hexanicotinate d'inositol	50.0 milligramme	Not calculated
Vitamine B6 Source : Chlorhydrate de pyridoxine	25.0 milligramme	50,000 µg
Folate Source : Folate	500.0 microgrammes	Not calculated
Vitamine B12 Source : Méthylcobalamine	500.0 microgrammes	Not calculated
3-alpha,16-alpha-Apovincaminic acid ethyl ester Source : Vinpocetine	5.0 milligramme	Not calculated
Piper nigrum Source : Fruit Potency : 95.0 % Piperine	2.5 milligramme	Not calculated

Non-medicinal ingredients

Hypromellose, Stéarate de magnésium

Recommended doses in Canada

Population	Age	Quantity per serving	Frequency
Adultes	Not specified	2.0 Capsule	1.0 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Helps to support cognitive health and/or brain function. Helps the body to metabolize carbohydrates, proteins and fats. Helps in tissue formation. Helps to form red blood cells. Helps to enhance cognitive function in adults. Helps to enhance memory in adults. Helps to support peripheral circulation. Provides antioxidants for the maintenance of good health. Use din Herbal Medicine as a hepatoprotectant/liver protectant. Used in Herbal Medicine to increase bile excretion by the liver (choleretic) and stimulate contraction of the gallbladder (cholagogue). Turmeric is traditionally used in Herbal Medicine as an anti-inflammatory to help relieve joint pain. Ashwagandha is traditionally used in Ayurveda as Rasayana (rejuvenative tonic). Ashwagandha is traditionally used in Ayurveda to relieve debility, especially during convalescence or old age. Ashwagandha is traditionally used in Ayurveda to balance aggravated Vata (nervine tonic, sedative). Ashwagandha is traditionally used in Ayurveda for memory enhancement.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80062994

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

List in the official revision dated 6 January 2016 (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).

List recorded in 2016. Photograph the packaging to check whether it has changed.

Has the product changed? Photograph the packaging.